Novo Nordisk
Novo Nordisk is a danish company founded in 1923 by David Thompson, August Krogh and Hans Christian Hagedorn.
All edits by Denis Maur
November 2021
Novo Nordisk announced it would acquire Dicerna Pharmaceuticals and its RNAi therapeutics, for $3.3 billion ($38.25 per share).
The treatments, produced by Novonordisk are:
Long-acting insulin
Tresiba®, insulin degludec
Xultophy®*, insulin degludec/liraglutide
Levemir®, insulin detemir
Human insulin
Insulatard®, human insulin
Actrapid®, human insulin
Mixtard® 30, biphasic human insulin
Mixtard® 40, biphasic human insulin
Mixtard® 50, biphasic human insulin
Premix insulin
Ryzodeg® 70/30, insulin degludec/insulin aspart
NovoMix® 30, biphasic insulin aspart
NovoMix® 50, biphasic insulin aspart
NovoMix® 70, biphasic insulin aspart
Glucagon-like peptide-1 (GLP-1)
Rybelsus, oral semaglutide
Victoza®, liraglutide
Ozempic®, semaglutide
Fast-acting insulin
Fiasp®, insulin aspart
NovoRapid® **, insulin aspart
NovoRapid® PumpCart®, pre-filled insulin pump cartridge
Oral antidiabetic agents
NovoNorm®, repaglinide
Find more companies like Novo Nordisk
